Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.63% |
| 5 | Energy | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
PUT
Chubb
CB
$132B
| $77K | ﹤0.01% |
+400
| New | +$78.4K |
|
1527
Helmerich & Payne
HP
$4.17B
| $75.1K | ﹤0.01% |
2,118
-2,007
| -49% | -$68.5K |
|
1528
Riskified
RSKD
$790M
| $73.6K | ﹤0.01% |
+15,145
| New | +$75.9K |
|
1529
Brunswick
BC
$5.24B
| $73.4K | ﹤0.01% |
847
-408,120
| -100% | -$33.3M |
|
|
UNVR
1530
DELISTED
Univar Solutions Inc.
UNVR
| $72.1K | ﹤0.01% |
+2,012
| New | +$71.5K |
|
1531
MaxLinear
MXL
$5.93B
| $72K | ﹤0.01% |
2,282
-198,016
| -99% | -$5.72M |
|
|
EMBK
1532
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $71.5K | ﹤0.01% |
25,000
| – | – |
|
1533
Zegna
ZGN
$3.68B
| $71.2K | ﹤0.01% |
+5,612
| New | +$69.9K |
|
1534
SEI Investments
SEIC
$13.3B
| $71K | ﹤0.01% |
+1,191
| New | +$69.3K |
|
1535
Transmedics
TMDX
$3.2B
| $70.1K | ﹤0.01% |
834
-266
| -24% | -$20.4K |
|
1536
CALL
Travelers Companies
TRV
$76.6B
| $69.5K | ﹤0.01% |
+400
| New | +$70.5K |
|
1537
Genesco
GCO
$378M
| $68.6K | ﹤0.01% |
2,741
+1,029
| +60% | +$29.8K |
|
1538
Sprout Social
SPT
$646M
| $67.8K | ﹤0.01% |
+1,468
| New | +$69.8K |
|
1539
Fathom Holdings
FTHM
$23.5M
| $67.5K | ﹤0.01% |
9,450
-76
| -0.8% | -$425 |
|
1540
Itron
ITRI
$4.28B
| $66.3K | ﹤0.01% |
+920
| New | +$58.2K |
|
|
X
1541
DELISTED
US Steel
X
| $64.5K | ﹤0.01% |
2,579
-5,716
| -69% | -$133K |
|
1542
Fidelity National Financial
FNF
$12.6B
| $63.8K | ﹤0.01% |
1,772
-159,944
| -99% | -$5.58M |
|
1543
CorVel
CRVL
$3.51B
| $63.3K | ﹤0.01% |
981
-912
| -48% | -$61K |
|
1544
Impinj
PI
$4.92B
| $62.8K | ﹤0.01% |
700
-104,300
| -99% | -$11.1M |
|
1545
Sysco
SYY
$39.8B
| $61.5K | ﹤0.01% |
829
-106,959
| -99% | -$7.91M |
|
1546
Snap-on
SNA
$20.3B
| $61.1K | ﹤0.01% |
212
+63
| +42% | +$16.3K |
|
|
VERV
1547
DELISTED
Verve Therapeutics
VERV
| $60.9K | ﹤0.01% |
3,250
+3,126
| +2,521% | +$52.1K |
|
|
K
1548
PUT
DELISTED
Kellanova
K
| $60.7K | ﹤0.01% |
959
| – | – |
|
1549
Samsara
IOT
$23.2B
| $60.4K | ﹤0.01% |
+2,181
| New | +$48.3K |
|
1550
CALL
Cameco
CCJ
$46.3B
| $59.5K | ﹤0.01% |
1,900
| – | – |
|
Similar funds
Steven Cohen's Q2 2023 Portfolio in Review
As of Q2 2023, Steven Cohen held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Steven Cohen withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Micron Technology worth $178M.
- Steven Cohen's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Steven Cohen added most to Microsoft in Q2 2023, an estimated $431M increase.
- Steven Cohen's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Steven Cohen fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Steven Cohen's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Steven Cohen opened 772 new positions and closed 858 in Q2 2023.
- Steven Cohen's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.